Reaktion #1576227

ord-d6941f5327b9443ca2e669d99fc92fd8

Reaktionsgleichung

On1nnc2ccccc21
1-hydroxybenzotriazole
CC#C[C@H](C)Oc1cc(N)c(Cl)cc1C(=O)O
(S)-4-amino-5-chloro-2-[(1-methyl-2-butynyl)oxy]benzoic acid
NC1C2CCN1CC(Cc1ccccc1)C2
8-amino-3-benzylazabicyclo[3.2.1]octane
CCN=C=NCCCN(C)C.Cl
WSC.HCl
CC#C[C@H](C)Oc1cc(N)c(Cl)cc1C(=O)NC1C2CCC1CN(Cc1ccccc1)C2
title compound
CC#C[C@H](C)Oc1cc(N)c(Cl)cc1C(=O)NC1C2CCC1CN(Cc1ccccc1)C2
(S)-N-(3-Benzyl-3-azabicyclo[3.2.1]oct-8-yl)-4-amino-5-chloro-2-(1-methyl-2-butynyl)oxybenzamide

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    SonstigeThe product was purified by silica gel column chromatography (5% methanol/chloroform)

Vorschrift

The condensation of 530 mg of (S)-4-amino-5-chloro-2-[(1-methyl-2-butynyl)oxy]benzoic acid with 850 mg of 8-amino-3-benzylazabicyclo[3.2.1]octane was conducted in a similar manner to that of the Example 34 by the use of WSC.HCl and 1-hydroxybenzotriazole (HOBT). The product was purified by silica gel column chromatography (5% methanol/chloroform) to give 220 mg of the title compound.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US05677311uspto-grants-1997_10